Editor

Lilly to acquire Orna Therapeutics to advance cell therapies

Preliminary AMT-191 phase 1/2a data shows sustained increases in α-Gal A enzyme activity in patients with Fabry Disease

Positive phase 3 topline results for Oral Infigratinib

Vir Biotechnology stock skyrockets 65% on positive prostate cancer treatment trial results

New strategic collaboration to develop new global medicines in oncology and immunology

Collaboration with Google Cloud to accelerate small-molecule discovery using AI agents

Bora Pharmaceuticals stock rises after signing $250m five-year manufacturing deal With GSK

ELRIG Cell & Gene Therapy 2026

AI platform PredictBBB.ai chosen for delivering 94% accuracy in next-gen drug development